← Leaderboards
Shrikumar Ambujakshan Nair
Affinergy ,Inc
$14,658,081
Attributed
$14,658,081
Total exposure
16
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.1M · FY2006–20$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$14,658,081 · 16
By mechanism
R44$11,502,977 · 5
R43$3,155,104 · 11
Top collaborators
No co-investigators on record.
Most similar at Affinergy ,Inc
Same institution · by research overlap
- Martyn Darby$22,135,337
- Hanne Gron$5,073,087
- Bruce Lamb$8,941,286
Others in their field
Top investigators on “Peptides”
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- John M Lachin · George Washington University$118,672,444
- David Heimbrook · Leidos Biomedical Research, Inc.$91,429,616
- Michael W Weiner · Northern California Institute Res &Educ$78,425,041
- Paul S. Aisen · Cognition Therapeutics, Inc.$69,846,203
- Rolf Apweiler · European Molecular Biology Laboratory$56,677,991
Research focus
PeptidesAffinityCellsTechnologyDiagnosticCostPrototypeLifePerformanceScale UpLeadUnited StatesProductionBindingDiagnosisErythrocytesCost SavingsEquipmentDetectionNew TechnologySamplingBlood CellsCommercializationCollagen
Grant awards (28)
Development of a peptide-based diagnostic for amyotrophic lateral sclerosis$299,778
R43 · FY2020 · NS · contact PI
Point-of-care device to identify patients at risk for preeclampsia$736,241
R44 · FY2019 · EB · contact PI
Novel technologies for detection of podocytes from preeclamptic patients$653,488
R44 · FY2019 · HD · contact PI
Development of a multiplex point-of-care assay to identify patients with Venous Thromboembolism$297,440
R43 · FY2019 · HL · contact PI
Point-of-care device to identify patients at risk for preeclampsia$752,918
R44 · FY2018 · EB · contact PI
Novel technologies for detection of podocytes from preeclamptic patients$638,707
R44 · FY2018 · HD · contact PI
A point-of-care assay to monitor tobramycin in cystic fibrosis patients$299,617
R43 · FY2018 · HL · contact PI
Novel technologies to remove obscuring blood from fine needle aspiration biopsies$203,640
R44 · FY2018 · GM · contact PI
Point-of-care device to identify patients at risk for preeclampsia$85,290
R44 · FY2018 · EB · contact PI
Novel technologies for detection of podocytes from preeclamptic patients$707,804
R44 · FY2017 · HD · contact PI
Novel technologies to remove obscuring blood from fine needle aspiration biopsies$696,963
R44 · FY2017 · GM · contact PI
Point-of-care device to identify patients at risk for preeclampsia$200,000
R43 · FY2017 · EB · contact PI
Point-of-care device to identify patients at risk for preeclampsia$52,200
R43 · FY2017 · EB · contact PI
Novel technologies to remove obscuring blood from fine needle aspiration biopsies$702,576
R44 · FY2016 · GM · contact PI
Novel technologies for improved slide quality of pancreatic fine-needle aspirates$301,009
R43 · FY2016 · DK · contact PI
Novel technologies for the detection of podocytes from preeclamptic patients$299,999
R43 · FY2016 · HD · contact PI
Novel technologies to remove obscuring blood from fine needle aspiration biopsies$698,109
R44 · FY2015 · GM · contact PI
Novel technology to remove obscuring blood from fine needle aspiration biopsies$304,833
R43 · FY2014 · GM · contact PI
Affinity Capture Peptides for Clinical Mass Spectrometric Assays in Plasma$283,799
R43 · FY2014 · GM · contact PI
Development of a novel clinical assay for measuring serum hepcidin levels$276,193
R43 · FY2014 · DK · contact PI
Peptide conjugation for Co-Delivery of Growth Factors and Stem Cells$731,310
R44 · FY2013 · GM · contact PI
Peptide conjugation for Co-Delivery of Growth Factors and Stem Cells$747,725
R44 · FY2012 · GM · contact PI
Self Assembling High Affinity Peptides for Point of Care Drug-Device Combinations$967,615
R44 · FY2010 · AI · contact PI
Click Chemistry for Immobilized Bone Morphogenetic Protein$1,135,117
R44 · FY2009 · GM · contact PI
Self Assembling High Affinity Peptides for Point of Care Drug-Device Combinations$975,043
R44 · FY2009 · AI · contact PI
Click Chemistry for Immobilized Bone Morphogenetic Protein$1,070,431
R44 · FY2008 · GM · contact PI
Self Assembling High Affinity Peptides for Point of Care Drug-Device Combinations$299,957
R43 · FY2008 · AI · contact PI
Click Chemistry for Immobilized Bone Morphogenetic Protein$240,279
R43 · FY2006 · GM · contact PI